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Objective: To determine the activation of Mitogen activated protein (MAP) kinases in and around cartilage
subjected to mechanical damage and to determine the effects of their inhibitors on impaction-induced
chondrocyte death and cartilage degeneration.
Design: The phosphorylation of MAP kinases was examined with confocal microscopy and immuno-
blotting. The effects of MAP kinase inhibitors on impaction-induced chondrocyte death and proteoglycan
(PG) loss were determined with ﬂuorescent microscopy and 1, 9-Dimethyl-Methylene Blue (DMMB)
assay. The expression of catabolic genes at mRNA levels was examined with quantitative real-time PCR.
Results: Early p38 activation was detected at 20 min and 1 h post-impaction. At 24 h, enhanced phos-
phorylation of p38 and extracellular signal-regulated protein kinase (ERK)1/2 was visualized in chon-
drocytes from in and around impact sites. The phosphorylation of p38 was increased by 3.0-fold in impact
sites and 3.3-fold in adjacent cartilage. The phosphorylation of ERK-1 was increased by 5.8-fold in impact
zone and 5.4-fold in adjacent cartilage; the phosphorylation of ERK-2 increased by 4.0-fold in impacted
zone and 3.6-fold in adjacent cartilage. Furthermore, the blocking of p38 pathway did not inhibit impac-
tion-induced ERK activation. The inhibition of p38 or ERK pathway signiﬁcantly reduced injury-related
chondrocyte death and PG losses. Quantitative Real-time PCR analysis revealed that blunt impaction
signiﬁcantly up-regulated matrix metalloproteinase (MMP)-13, Tumor necrosis factor (TNF)-a, and
ADAMTS-5 expression.
Conclusion: These ﬁndings implicate p38 and ERK mitogen activated protein kinases (MAPKs) in the post-
injury spread of cartilage degeneration and suggest that the risk of post-traumatic osteoarthritis (PTOA)
following joint trauma could be decreased by blocking their activities, which might be involved in
up-regulating expressions of MMP-13, ADAMTS-5, and TNF-a.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Joint injury is a common cause of osteoarthritis (OA) in young
adults and is responsible for about 12% of all OA of the lower
extremity joints1e3. In this disorder the initial cartilage lesion is
caused by direct mechanical force. Examination of injured cartilage
shows loss of proteoglycan (PG) from the extracellular matrix
(ECM) and disruption of collagen ﬁber network4,5. More recentJames A. Martin, Department
a Hospitals and Clinics, 500
owa 52242, USA.
rtin).
s Research Society International. Pﬁndings showed that chondrocyte density is progressively
decreased following blunt impact6e8. The reduction of cellularity is
correlated with the severity of post-traumatic osteoarthritis
(PTOA)9. Cell death initiated by mechanical trauma has been
observed both in vivo and in vitro10e13. The mechanisms involved in
this type of trauma-induced cell death include necrosis14, chon-
dropotosis (a variant of apoptosis in chondrocytes)15, and
apoptosis16e19. While the direct impact causes necrosis of chon-
drocytes, the spreading of cell death into adjacent cartilage is most
likely induced by apoptosis/chondropotosis which is a highly
regulated process carried out by intracellular signaling cascades.
Mitogen activated protein (MAP) kinases, p38, extracellular
signal-regulated kinases (ERKs), and c-Jun N-terminal kinasesublished by Elsevier Ltd. All rights reserved.
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lating matrix metalloproteinases (MMPs)20 that degrade the ECM.
The activation of MAP kinases has been observed in various oste-
oarthritic-cartilage-damage models, such as IL-1beta induced
chondrolysis21and cartilage damage induced bymatrix degradation
products including ﬁbronectin fragments22 and collagen frag-
ments23,24. Furthermore, MAP kinases also play essential roles in
apoptotic pathways. In Hela cells, p38 MAP kinase was activated in
response to apoptotic signals initiated by the depletion of Cdc7,
a key kinase involved in DNA replication and checkpoint
response25. The death of a human Leukemia cell line, HL-60,
induced by diallyl disulﬁde (DADS) was mediated by the activation
of p38 MAP kinase while the activity of another MAP kinase, ERK,
was inhibited26. Similar results were observed in another Leukemia
cell line, U937, when treated with phospholipase A227. However,
when human gastric cells were treated with hydrogen peroxide,
both ERK and JNK MAP kinases were activated, resulting in
apoptosis28. Furthermore, in an experimental OA animal model
created with sectioning of the anterior crucial ligament, the acti-
vation of MEK1/2, the upstream kinase of ERK1/2, and p38 MAP
kinase was demonstrated to be responsible for the up-regulation of
iNOS and COX-2 which mediate chondrocyte apoptosis29.
Because of their involvement in cartilage damage/chondrolysis
pathways, we hypothesized that MAP kinases, especially ERK and
p38, activated in response to a single blunt impact injury contribute
to chondrocyte death and PG loss in and around the impact site. To
test this we used an osteo-chondral explant model to study the
time course of MAP kinase activation and to study the effects of
speciﬁc inhibitors on impact-related chondrocyte death and PG
losses in impacted and surrounding cartilage.
Methods
All common chemicals and reagents were purchased from RPI
Corp. (Mount Prospect, IL) or Sigma Chemical Co. (St. Louis, MO).
Dulbecco’s Modiﬁed Eagle Medium (DMEM), F-12, Fetal Bovine
Serum (FBS), and Hanks’ Balanced Salt Solution (HBSS) were from
Gibco/Invitrogen (Carlsbad, CA). Methanol-free 16% para-
formaldehyde solution was purchased from Thermo Fisher Scien-
tiﬁc (Rockford, IL). Goat serum was from SigmaeAldrich (St.
Louis, MO). Alexa Fluor 568 F(ab0)2 fragment of goat anti-rabbit
IgG (Hþ L) was obtained from Invitrogen (Carlsbad, CA). VEC-
TASHIELD mounting medium with DAPI was from Vector Labora-
tories, Inc. (Burlingame, CA). Protease inhibitor cocktail set III
reagent was purchased from Calbiochem/EMD (Gibbstown, NJ).
Bicinchoninic Acid (BCA) Protein Assay Reagent was from Thermo
Scientiﬁc/Pierce Biotechnology (Rockford, IL). Total and phosphor-
speciﬁc p38 (Thr180/Tyr182), JNK1/2 (Thr183/Tyr185), ERK1/2
(Thr202/Tyr204) antibodies and horse radish peroxidase (HRP)-
conjugated goat anti-rabbit IgG were from Cell Signaling Tech-
nology (Danvers, MA). The chemical inhibitors of p38 MAP kinase,
SB203580 and SB202190, and inhibitors of MEK1/2/ERK1/2, and
U0126 were purchased from CalBiochem (San Diego, CA).
Dimethyl Sulfoxide (DMSO) (molecular biology grade, 99.9%), 1,
9-Dimethyl-Methylene Blue (DMMB), and papain were obtained
from SigmaeAldrich (St. Louis, MO). Calcein AM and ethidium
homodimer-2 (EthD-2) were from Invitrogen (Carlsbad, CA).
Pure Nitrocellulose Membranes (0.45 mM) were purchased from
Bio-Rad Laboratories (Hercules, CA). SuperSignal West Dura
Extended Duration Substrate was from Thermo Scientiﬁc/Pierce
Biotechnology (Rockford, IL). BioMax XAR Film was purchased
from Kodak Film (Rochester, NY). Biopsy punches were from
Miltex (York, PA).
Stiﬂe joints were taken from 18 to 20-month-old cows from
a local abattoir. 2.5 cm 2.5 cm (W L) osteo-chondral explantswith 0.5e1.0 cm-thick subchondral bone were manually sawed
from the central loaded area of the lateral tibial plateau. The
explants were then washed once with 1 HBSS containing antibi-
otics, placed in culturemedia [DMEM/F-12 (50%/50%)/10% FBS, with
antibiotics] and incubated overnight at 37C (5% CO2, and 5% O2).
A drop tower was employed to impart loads to an indenter
resting on the cartilage surface of the explants. The indenter was
a ﬂat-faced 5.0 mm diameter brass rod with rounded edges
(r¼ 1 mm). A 2 kg mass was dropped onto the rod from a height of
14 cm resulting in impact energy density of 14 J/cm2. Impacted
explants were placed in fresh culture media and incubated at 37C,
5% CO2, and 5% O2 for various times. Impact sites were visible to the
naked eye immediately after insult [Fig. 1(A)]. Safranin-O histology
revealed local delamination and superﬁcial/transitional zone
ﬁssuring typical of high energy blunt impact injuries [Fig. 1(C)].
In order to visualize the distribution of phosphorylated kinases,
cartilage from explants at 24 h post-impaction or from non-
impacted explants at the corresponding time point was embedded
in Tissue Freezing Medium (Triangle Biomedical Sciences, Durham,
NC) and full-thickness sagittal sections were cut at 5 mme10 mm
intervals. The sections were ﬁxed with 4% paraformaldehyde for
15 min at room temperature (RT), washed three times with 1 PBS,
and blocked for 1 h at RT with 5% goat serum diluted in 1 PBS
containing 0.3% Triton X-100. After blocking, sections were incu-
bated overnight at 4C with anti-phospho p38 antibody or anti-
phospho-ERK1/2 antibody diluted 1:100 in 1% BSA/PBS containing
0.3% Triton X-100. After threewashes, sections were incubatedwith
Alexa 568 conjugated goat anti-rabbit IgG diluted 1:400 in 1% BSA/
PBS containing 0.3% Triton X-100 for 1e2 h at RT. After ﬁnal washes
with 1 PBS, sections were mounted in VECTASHIELD/DAPI
mounting medium. Alexa 568 ﬂuorescence representing phos-
phorylated MAP kinases and DAPI ﬂuorescence representing cell
nuclei were imaged with a Zeiss 710 confocal microscope.
Cartilage for phosphoprotein analysis was harvested at 20 min,
1 h, 3 h, 6 h,12 h, 24 h, and 48 h post-impact. Non-impacted control
cartilage was harvested at the same time points. 6 and 8 mm
diameter biopsy punches and an osteotome were used to separate
the impacted and annulus cartilage from the bone [Fig. 1(B)].
Impacted and annulus cartilage, both cut in half with scalpels, were
immediately submerged into cold lysis buffer (150 mM NaCl,
10 mM Tris, pH 7.0, 0.1% SDS, 1% Triton X-100, 1% sodium deoxy-
cholate, 1 mM EGTA, 50 mM NaF, 1 mM Na3VO4, 1 mM glycerol
phosphate, 2.5 mM sodium pyrophosphate, 10 mg/ml aprotinin,
10 mg/ml leupeptin, 1 mM EDTA). Protease inhibitor cocktail set III
was diluted in lysis buffer (1:100). The tissue was incubated in lysis
buffer with gentle shaking at 4C overnight.
After incubation with lysis buffer, supernatants were removed
and total protein concentration was determined using the BCA
protein assay reagent. Cartilage tissue lysates were denatured with
2 sample buffer and reduced with 0.05 M DTT prior to electro-
phoresis. Lysate volumes containing 5 mg protein were fractionated
on 10% acrylamide SDS gels and electrolotted to nitrocellulose
membranes. The blots were blocked with 5% nonfat dry milk in
20 mM Tris buffer, pH 7.4, containing 140 mM NaCl (TBS) and 0.1%
Tween 20 (TBST) for 1 h at RT and incubated overnight at 4C with
the anti-total or anti-phospho-speciﬁc kinase antibodies diluted
1:1,000 in 5% BSA in TBST (BSA/TBST). This was followed by
washing and reaction for 1 h with HRP conjugated goat anti-rabbit
IgG diluted 1:2,000 in 5% BSA/TBST. After washing, the blots were
reacted with SuperSignal West Dura substrate for 5 min. Blots were
then exposed to KODAK BioMax XAR ﬁlm. Image J software was
employed to measure the integrated density (ID) of each band on
a blot. The relative fold increase of ID over controls was calculated
as: IDpMAPK (impaction) X ID tMAPK (control)/[IDpMAPK (control) X ID tMAPK
(impaction)]. The means and 95% conﬁdence intervals (CI) of the
Fig. 1. Osteo-chondral explant blunt injury model. (A) The image shows the gross appearance of a 14 J/cm2 blunt impact injury on the surface of a typical osteo-chondral explant.
The center of the 2.5 cm 2.5 cm explant was struck once with a 5-mm diameter platen. (B) Illustration of the method employed to harvest cartilage tissue from a traumatized
explant. 6 mm punches were used to harvest the impact site itself and 8 mm punches were used to harvest an adjacent annular ring of cartilage surrounding the impact site. (C) A
high resolution scanned image of a safranin-O-, fast green-, and hematoxylin-stained section through the middle of an impact site. Blue arrows show the approximate boundaries of
the platen contact. The surface is undamaged outside the contact area, but cartilage damage as superﬁcial delamination and cracking are apparent within the impact site. The inset
shows a close-up view of cracks running from the surface down to the transitional zone.
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three individual experiments.
A p38 inhibitor (SB202190) and an ERK inhibitor (U0126) were
tested to determine if blocking the p38 pathway inhibits impact-
induced ERK activation. Prior to impaction, osteo-chondral explants
were pre-treated with either 10 mM SB202190 or 10 mM U0126 for
90 min. After 24 h of post-impaction, cartilage discs were dissected
from the impact zone and area surrounding the zone with 6-mm
and 8-mm biopsy punches. Cartilage discs from non-impacted
explants or from impacted explants without inhibitor pre-treat-
ment were also collected at the same time point. Blots of cartilage
lysates were probed with anti-total or e phospho-ERK1/2 antibody
as described above.
Two p38 inhibitors (SB203580, SB202190) and an ERK inhibitor
(U0126) were tested for effects on impact-induced changes in
viability and PG content. All three inhibitors were used at
a concentration of 10 mM. Controls were incubated with equivalent
volumes of solvent (DMSO), which was 0.1% in culture media.
Explants were incubated in mitogen activated protein kinases
(MAPK) inhibitors starting 90 min prior to impaction and were
returned to culture media containing the inhibitors immediately
after impaction. The media were changed and the inhibitors were
re-applied every other day. On day 7 post-impact chondrocyteviability in the impact and annulus sites was evaluated by confocal
microscopy. Brieﬂy, Osteo-chondral explants were incubated with
1.0 mg/ml calcein AM (live cell staining) and 1 mM ethidium
homodimer (dead cell staining) for 45 min, and then washed with
1HBSS once. Z-section images at 20 mm intervals were taken from
three different sites in impacted zone and three in the area
surrounding the impacted zone, respectively. Live and dead cells
were counted with Image J. The ratio of live cell count to total cell
count (chondrocyte viability) was calculated and averaged among
three individual experiments. Variances are reported in terms of
95% CIs. Effects were analyzed using one-way ANOVA and the
Dunnett test.
The effects of p38 and ERK inhibitors on impact-induced PG loss
were examined with DMMB assays. On day 7 post-impact cartilage
samples from impact sites were dissected with a 4-mm biopsy
punch and osteotome. Five or six cartilage disks in the area imme-
diately next to the impact site were also recovered with 4-mm
biopsy punches. The mass of the harvested cartilage disks was
measured to obtain wet weight and the cartilage was incubated in
papain digest buffer containing 0.5 mg/ml papain, 5 mM L-cysteine,
0.1 M HNaPO4 (pH 7.5) for 4 h at 65 C. The total sulfated glycos-
aminoglycan (PG) concentration in the papain digest was measured
using DMMB reagent with shark chondroitin sulfate as a standard.
Fig. 2. Effect of blunt impact on enhancing phosphorylation of p38 and ERK MAP kinases. Osteo-chondral explants were pre-equilibrated overnight in DMEM/F12/10% FBS prior to
blunt impaction. Cartilage surfaces were subjected to a single blow with an energy of 14 J/cm2. After 24 h, cartilage discs from the impacted zone and area immediately next to the
zone were harvested with 5-mm biopsy punches. Right after harvesting, those discs were immersed into liquid nitrogen for at least 10 min before being transferred into 80C
freezer for storage. Full-thickness of cartilage discs were sectioned at 5 mm or 10 mm intervals. Cartilage sections were immediately ﬁxed with 4% paraformaldehyde. Anti-phospho
p38 or anti-phospho-ERK1/2 antibody and Alexa Fluor 568 conjugated goat anti-rabbit antibody were used for indirectly staining of phosphorylated p38 or ERK MAP kinases in
chondrocytes. Those sections were counter-stained with DAPI. A Zeiss 710 confocal microscope was utilized to image the distribution of phosphorylated p38 or ERK1/2 MAP kinases.
Fig. 3. Short-term Effects of Blunt Impact on MAP kinases. Western blots show results
for cartilage from non-impacted control explants (“C”) or from impact sites (“I”) and
annulus sites (“A”) from injured explants. The samples were harvested at 20 min, 1 h,
and 3 h post-impact or at equivalent culture times in controls. Blots were probed with
antibodies recognizing total (t) and phosphorylated (p) forms of JNK1/2 and p38 (A)
and ERK1/2 (B).
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lage disk and was averaged among three individual experiments.
Uncertainty estimates are reported as 95% CIs. One-way ANOVA and
HolmeseSidak test was employed for statistical analysis.
MMP-13, Tumor necrosis factor (TNF)-a, and ADAMTS-5
expressionwas examined at the mRNA level with quantitative real-
time PCR (qRT-PCR). Dermal punches were used to dissect
impacted, annulus, and control cartilage from four different
explants. The cartilage discs were ﬂash frozen in liquid nitrogen
and cryosectioned. Total RNA was extracted using TRIZOL (Invi-
trogen) and was puriﬁed using Qiagen RNEasy Kits (Valencia, CA).
The concentration was measured with a Nanodrop spectrometer.
Sample volumes containing 50 ng total RNA were assayed by qRT-
PCR using Superscript III Platinum SYBR Green One-Step qRT-PCR
kits (Invitrogen). Primers for bovine b-actin, MMP-13, TNF-a, and
ADAMTS-5 were obtained from Integrated DNA Technologies
(Coralville, IA) (sequences available upon request). Data were
obtained using an ABI Prism 7700 Sequence detection System
(Applied Biosystems, Foster City, CA). Relative gene expression
(Impact or Annulus/Control) was calculated using a comparative CT
method. Results are reported as fold differences (266CT). Treat-
ment effects (impact vs annulus vs control) were evaluated using
one-way ANOVA and the HolmeseSidak test.
Results
Immunoﬂuorescence staining revealed that phosphorylation of
p38 MAP kinase in the impact zone was greatly increasedcompared to non-impacted cartilage at 24 h after impaction (Fig. 2).
The phosphorylation level of p38 in cells from cartilage adjacent to
the impact zone was also higher than that in non-impacted
controls. However, the level of p38 phosphorylation in adjacent
Fig. 4. p38 and ERK MAP Kinase Activation at 12 and 24 h post-impact. Western blot results are shown for cartilage from non-impacted control explants (“C”), or from impact sites
(“I”) and annulus sites (“A”) from injured explants. (A) Representative blots of extracts from cartilage harvested at 12 or 24 h after impact. The blots were probed for total p38 or
phosphorylated p38. (B) Fold increase in phosphorylation (impact or annulus vs control) based on densitometric analysis of Western blots from at least three individual experi-
ments. Error bars stand for 95% CIs. (C) Western blots were probed for total and phosphorylated ERKs at 24 h in untreated control or impacted cartilage from ﬁve individual osteo-
chondral explants. Results are shown for control, impact and annulus sits (“C”, “I”, “A”). (D) Average fold increase in phosphorylation (relative to non-impacted control) based on
densitometric analysis from six individual experiments. Error bars show 95% CIs.
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most of phosphorylated p38 was concentrated in the nuclear or
peri-nuclear area. Similar to p38, ERK phosphorylation was also
enhanced by blunt impact on cartilage, not only in the impact zone
but also in the adjacent area.
Immunoblots showed elevated phosphorylation of JNK-1 (p46)
and JNK-2 (p54) in both the impact and annulus cartilage at 20 min
post-impaction. However, the enhanced phosphorylation declined
to baseline at 1 h post-impaction. The activation of p38 MAP kinase
was also detected at 20 min post-impaction: phosphorylation in
the impacted zone and annulus increased by 2.7- fold and 3.6-fold,
respectively. At 1 h post-impaction p38 phosphorylation levels
increased to 3.5- and 6.8-fold greater than control in the impact site
and annulus respectively [Fig. 3(A)]. In contrast, ERK1/2 activation
was not detected within 3 h of post-impaction [Fig. 3(B)].
The activation of p38 MAP kinase was apparent in impacted and
annulus cartilage at 12 h post-impaction and was still detectable at
24 h after impact [Fig. 4(A)]. Densitometric analysis of blots from
three different experiments showed that at 12 h post-impaction
compared to non-impacted controls, the phosphorylation in
impacted cartilage was increased by 2.5 0.07-fold and in adjacent
cartilage by 4.2 0.62 fold, respectively. At 24 h post-impaction,
the phosphorylation levels were still 3.01.92 fold higher inFig. 5. Effect of blocking p38 MAP kinase activation on blunt impact-induced ERK activa
impacted (I) or annulus (A) cartilage. Experimental groups included control explants withou
inhibitor, or with SB202190 (SB.), a p38 MAP kinase pathway inhibitor. Lysate proteins wer
were probed with anti-total ERK (t-ERK1/2) or anti-phospho-ERK (p-ERK1/2) antibodies.
inhibitors. They are designated as U.1, SB.1, U.2, and SB.2 on the blots, respectively.impact sites and 3.3 2.00-fold higher in annulus sites when
compared to non-impacted controls [Fig. 4(B)].
The activation of ERKs was still undetectable in either the
impacted or annulus zones at 12 h after impaction (data not
shown). However, at 24 h post-impaction, the phosphorylation of
both ERK-1 and -2 was greatly elevated in impacted and annulus
cartilage [Fig. 4(C)]. Data from six individual experiments showed
the average fold increase of ERK-1 phosphorylation in the impacted
zone was 5.8 1.04 and 5.4 0.88 in cartilage surrounding the
impacted zone. The phosphorylation of ERK-2 was increased by
4.0 0.64-fold in impacted zone and by 3.6 0.56-fold in annulus
cartilage [Fig. 4(D)], Neither JNKs was activated in impacted or
annulus cartilage at 12 h or 24 h of post-impaction (data not
shown).
Since p38 activation occurred much earlier than ERK1/2 did, the
interrelationship of p38 pathway and ERK pathway was also
examined. The p38 pathway speciﬁc inhibitor, SB202190, did not
inhibit the activation of ERK1/2 at 24 h post-impaction (Fig. 5). On
the other hand, impaction-induced ERK1/2 phosphorylation was
reduced to basal levels by the MEK1/2/ERK1/2 inhibitor, U0126.
Treatment with speciﬁc MAP kinase inhibitors greatly enhanced
cell viability of impacted explants. Representative images show the
cell-sparing effects of the p38 MAPK inhibitor SB202190 [Fig. 6(A)].tion. At 24 h post-impaction, tissue lysates from non-impacted controls (N. C.), from
t any inhibitor treatments, and explants pre-treated with U0126 (U.), a MEK1/2/ERK1/2
e resolved by SDS-PAGE and blotted onto nitrocellulose membranes. The membranes
In these studies, two sets of osteo-chondral explants were pre-treated with above
Fig. 6. Effects of MAP Kinase Inhibitors on Chondrocyte Viability after Impact Injury. (A) Confocal microscope images show impact and annulus sites on explants stained with
calcein AM and ethidium homodimer on day 7 post-impaction. Green-stained cells are viable and red stained cell are dead. The explants shown in the panels on the right were
treated with 10 mM p38 MAP kinase inhibitor (þSB202190). (B) The percentage of viable cells measured in non-impacted controls (N. C.), non-impacted controls treated with
SB202190 only (SB90), impact sites in explants treated with SB202190 (SB90þI., I.) or annulus sites in treated explants (SB90þI., A.), and impact and annulus sites in untreated
explants (Impact Only; I. O., I.; I. O., A.) (N¼ 9; Error bars stand for 95% CIs) (C) Percentage viability in non-impacted controls (N.C.), non-impacted controls treated with 10 mM
ERK inhibitor, U0126, only (U0126) and impact and annulus sites treated with (U. þ I., I.; U. þ I., A.) or without UO126 (Impact Only; I. O., I.; I. O.,A.) (N¼ 9; Error bars stand for
95% CIs). The viability of each group was compared to that of impact site from impacted explants without inhibitor treatment (Impact Only, I. O.).
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Table I
Effects of MAPK inhibitors on reducing blunt impact-induced PG depletion
Group [PG] mg/mg
wet cartilage
N 95% CIs P
Mean S.D. Upper
limit
Lower
limit
Non-impacted control 65.0 2.65 3 68 62 0.0007
DMSO Only 64.7 7.51 3 73.2 56.2 0.0062
D. þ I., I. 38.5 4.17 3 43.22 33.78 N/A
D. þ I., A. 45.9 3.49 3 49.85 41.95 0.0779
Impact Only, I. 47.4 8.14 3 56.61 38.19 0.1672
Impact Only, A. 42.6 4.92 3 48.17 37.03 0.3327
SB203580 Only 57.2 4.33 3 62.1 52.3 0.0057
SB80 þ I., I. 54.1 7.18 3 62.22 45.98 0.0313
SB80 þ I., A. 53.3 8.37 3 62.77 43.83 0.0518
SB202190 Only 59.6 6.01 3 66.4 52.8 0.0075
SB90 þ I., I. 75.2 15.71 3 92.98 57.42 0.0174
SB90 þ I., A. 70.7 13.32 3 85.77 55.63 0.0162
U0126 only 54.2 9.56 3 65.02 43.38 0.0596
U. þ I., I. 71.5 4.49 3 76.58 66.42 0.0007
U. þ I., A. 66.2 3.83 3 70.53 61.87 0.0011
The PG contents in impacted cartilage or non-impacted controls were measured at
Day 7of post-impaction. In impacted explants, cartilage directly from the impact
zone (I.) along with areas immediately adjacent to the zone (A.) were assayed. All
values were compared to that of the impact site of impacted cartilage treated with
DMSO (D. þ I., I.).
Table II
Up-regulation of catabolic genes by blunt impact
Group 2DDCT N 95% CIs P
Mean S.D. Upper limit Lower limit
MMP-13
Control 1 0.90 3 2.02 0.02 N/A
Impact 2.57 0.03 3 2.6 2.54 0.0394
Annulus 3.11 0.11 3 3.23 2.99 0.0158
TNF-a
Control 1 0.32 3 1.36 0.64 N/A
Impact 2.23 0.31 3 2.58 1.88 0.0088
Annulus 2.91 0.60 3 3.59 2.23 0.0082
ADMTS-5
Control 1 0.52 3 1.59 0.41 N/A
Impact 2.01 0.07 3 2.09 1.93 0.0290
Annulus 1.60 0.18 3 1.8 1.4 0.1320
ThemRNA levels of target genes in cartilage at 6 h of post-impaction weremeasured
with quantitative real-time PCR. The relative expression of target genes was
calculated as ratios of CT values in impacted or annulus cartilage to those in
untreated control cartilage (2DDCT).
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annulus sites from 61.5% 6.01 and 60.9% 7.5 to 87.7% 4.97
(P < 0.0001) and 83.8% 6.53 (P¼ 0.0002), respectively. Those
values were close to the percentages in non-impacted controls or
cartilage treated with the inhibitor only [Fig. 6(B)]. Another p38
MAP kinase inhibitor, SB203580, also enhanced chondrocyte
viability in impact and annulus sites but with less extent when
compared to SB202190 (data not shown). Similar to p38 inhibitors,
the MEK/ERK inhibitor, U0126, enhanced average live cell
percentage in impact sites from 61.5% 6.01 to 93.4% 2.42 and in
annulus sites from 60.9% 7.5 to 82.1% 2.09 respectively [Fig. 6
(C)]. This effect was statistically signiﬁcant (P < 0.0001 for both
the impact site and annulus site) and resulted in viable cell
percentages similar to those in non-impacted cartilage or cartilage
treated with the inhibitor only.
The effects of MAPK inhibitors on PG content in impact and
annulus cartilage were measured at 7 days post-impaction and in
non-impacted controls (Table I). The average PG content in
impacted and annulus cartilage was 38.5 mg PG/mg wet cartilage
and 45.9 mg PG/mg wet cartilage respectively, levels that were
signiﬁcantly lower than those in non-impacted cartilage (65.0 mg
PG/mg), or cartilage treated with DMSO only (64.7 mg PG/mg).
However, when the p38 MAPK inhibitor SB202190 was constantly
present in the cultures, PG content increased to 75.2 mg PG/mg in
impact sites and to 70.7 mg PG/mg in annulus sites, effects that were
highly signiﬁcant (P¼ 0.0174 for impact sites and P¼ 0.0162 for
annulus sites). A second p38 inhibitor, SB203580, increased PG
content from 38.5 mg PG/mg to 54.1 mg PG/mg in impact sites and
from 45.9 mg PG/mg to 53.3 mg PG/mg in annulus sites. Although
the increase in PG concentration was statistically signiﬁcant in
impact sites (P¼ 0.0313), SB203580 did not completely restore PG
content to the level in non-impacted controls. U0126, an ERK
pathway inhibitor, also signiﬁcantly enhanced PG content, from
38.5 mg PG/mg to 71.5 mg PG/mg in the impact sites and from
45.9 mg PG/mg to 66.2 mg PG/mg in annulus sites. The PG levels in
U0126 treated impacted cartilage were similar to that in non-
impacted controls (65.0 mg PG/mg). The effects of U0126 on PG
contents in both impact sites and annulus sites were statistically
signiﬁcant (P¼ 0.0007 for impact sites and P¼ 0.0011 for annulus
sites).
Quantitative RT-PCR analysis of mRNA levels revealed signiﬁ-
cantly elevated expression of MMP-13, TNF-a and ADAMTS-5 in
cartilage from the impacted zone and surrounding area at 6 h post-
impaction (Table II). Compared to controls, impact zones showed
increased expression of MMP-13 (2.6-fold, P¼ 0.0394), TNF-a (2.2-
fold, P¼ 0.0088), and ADAMTS-5 (2.0-fold, P¼ 0.0290). Even higher
relative expression of MMP-13 and TNF-awas detected in cartilage
surrounding the impacted zone (3.1-fold and 2.9-fold respectively).
These differences were statistically signiﬁcant (For MMP-13:
P¼ 0.0158; For TNF-a: P¼ 0.0082). Although the expression of
ADAMTS-5 in the surrounding annulus cartilagewas 1.6-fold higher
than that in controls, the differencewas not signiﬁcant (P¼ 0.1320).
Discussion
In-vitro studies show that mechanical trauma to articular
cartilage causes immediate physical damage to the collagen
network30 and biologic responses that lead to increased ECM
turnover31,32, elevated cartilage degradation33,34, and reduced cell
viability35e38. Previously published data based on our in vitro injury
model showed that the caspase inhibitor z-VAD-fmk saved
approximately 30e50% of cells that otherwise died within 24 h of
impaction45. This indicated that caspase-dependent apoptosis was
responsible for 30e50% of blunt impaction-induced cell death.
However, more work needs to be done in order to investigate thecauses of cell death at different time points and at different energy
levels of a single blunt impact on cartilage.
The early activation of p38 and JNK MAP kinases in impact and
adjacent cartilage could be the direct result of mechanical force.
Deformation of the ECM can be sensed by trans-membrane
receptors, such as beta 1 integrins, which signal viaMAP kinases39.
The beta 1 integrin-p38 pathway was shown to mediate p53 acti-
vation and apoptosis of smooth muscle cells subjected to cyclic
mechanical stretch40. Therefore, the early activation of p38 and JNK
kinases in our model suggest apoptotic pathways might be turned
on, which in turn induces cell death in both impact zone and in
cartilage adjacent to the zone.
Cytokines or fragmented ECM components including ﬁbro-
nectin, collagen, and hyaluronic acid, might well be responsible for
inducing the activation of p38 and ERK1/2 at later time
points22,41,42. ERKs have been shown to mediate signaling to
downstream kinases and transcription factors, resulting in
increased expression of genes involved in cell proliferation and
migration, which may be part of a reparative process43. On the
other hand, ERKs modulate apoptotic pathways in chondrocytes
L. Ding et al. / Osteoarthritis and Cartilage 18 (2010) 1509e15171516and have been shown to act synergistically with p38 MAP kinase to
promote apoptosis44. The strong beneﬁcial effects of the ERK
inhibitor on viability in our model lend support to this hypothesis.
The results of this investigation conﬁrmed sequential activation
of p38 and ERK1/2 after blunt impact injury. The kinases were
activated not just in cartilage damaged directly by impaction, but in
the adjacent undamaged cartilage. Impact-related chondrocyte
mortality and cartilage PG loss in both impacted and adjacent
cartilage were inhibited by p38 and ERK inhibitors, indicating that
these kinases play a role in initiating and propagating chondrolytic
activity after mechanical injury. Since these results raised the
possibility that p38 and ERK1/2 act in the same pathway,we studied
the effect of p38 inhibition on ERK activation following impaction.
The results clearly showed that ERK activation was not affected by
blocking the p38 pathway. However, the two pathways might
converge in the nucleus to act together on transcription factors that
regulate catabolic and anabolic pathways and even cell death.
Although we observed that inhibiting p38 pathway or ERK
pathway effectively reduced impaction-induced cell death and ECM
depletion, our ﬁndings do not allow us to conclude if increased PG
content associated with inhibitor treatments were due to reduced
catabolic activity, increased anabolic activity, or simply to preser-
vation of viability (or all three). In addition, sample-to-sample
variation among the osteo-chondral explants used for this study
might occasionally have led to increases in phospho/total ERK1/2
ratios that were not related to impaction. Nevertheless, densi-
tometry data based on multiple blots showed that, in relation to
total ERK1/2, phospho-ERK1/2 increased several fold by 24 h of
post-impaction, a change that did not occur consistently in non-
impacted controls.
The signiﬁcantly elevated expression of MMP-13, TNF-a and
ADAMTS-5 at 6 h post-impaction indicate that MAP kinase activa-
tion leads to overexpression of catabolic factors. This hypothesis is
based on the observations that both p38 and ERK MAP kinases play
important roles in up-regulating genes involved in cartilage
degradation22,46, mediating TNF-a induced suppression of type II
collagen and link protein47.
Previous work in our laboratory demonstrated that acute
impact-induced cell deathwas substantially inhibited by immediate
post-impact treatment (within 4 h) with n-acetyl cysteine (NAC),
a free radical scavenger45. However, without any further interven-
tion, the catabolic activities of surviving cells may still lead to
progressive degeneration. In that regard, the complete blockade of
PG depletion by the MAP kinase inhibitors tested in our model
systemsuggests theymaybe useful as a follow-up treatment toNAC.
Our model is limited by the absence of synovium and other
factors that govern cartilage responses in clinically-relevant joint
injuries. Although we chose to focus here on the effects of impact
injury itself, post-impaction static or cyclic loading might as well
contribute to the propagation of ECM degradation by activating or
strengthening multiple catabolic pathways. The long-term devel-
opment of PTOA is impossible to predict based on events studied
here, which spanned only the ﬁrst 24 h of post-injury. Nevertheless,
our study supports the concept that cartilage degeneration is not an
inevitable consequence of mechanical injury and points to multiple
pathways involved in impaction-induced cartilage degradation as
promising targets for testing in in vivo models.
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